CRDF - CIK 0001213037
Cardiff Oncology, Inc. has filed 1,000 documents with the SEC between 2012 and 2026. The most frequent type is major company event (391 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-03-13 | 2025-03-11 |
| Insider trade | 4 | 2025-03-13 | 2025-03-11 |
| Insider trade | 4 | 2025-03-13 | 2025-03-11 |
| SEC correspondence | UPLOAD | 2025-03-06 | - |
| Major company event | 8-K | 2025-02-27 | 2025-02-27 |
| Securities registration | S-3 | 2025-02-27 | - |
| Annual report | 10-K | 2025-02-27 | 2024-12-31 |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| SCHEDULE 13G/A | - | 2025-02-05 | - |
| Major company event | 8-K | 2025-01-06 | 2025-01-03 |
| Insider trade | 4 | 2024-12-18 | 2024-12-16 |
| SCHEDULE 13G | - | 2024-12-17 | - |
| Insider trade | 4 | 2024-12-16 | 2024-12-12 |
| Insider trade | 4 | 2024-12-12 | 2024-12-11 |
| Prospectus supplement | 424B5 | 2024-12-11 | - |
| Major company event | 8-K | 2024-12-10 | 2024-12-10 |
| Major company event | 8-K | 2024-12-10 | 2024-12-10 |
| Passive ownership stake | SC 13G | 2024-11-08 | - |
| Major company event | 8-K | 2024-11-07 | 2024-11-07 |
| Quarterly report | 10-Q | 2024-11-07 | 2024-09-30 |
| Passive ownership stake | SC 13G | 2024-10-24 | - |
| Major company event | 8-K | 2024-08-08 | 2024-08-08 |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Insider trade | 4 | 2024-07-01 | 2024-06-27 |
| Insider trade | 4 | 2024-07-01 | 2024-06-27 |
| Insider trade | 4 | 2024-07-01 | 2024-06-27 |
| Insider trade | 4 | 2024-07-01 | 2024-06-27 |
| Insider trade | 4 | 2024-07-01 | 2024-06-27 |
| Insider trade | 4 | 2024-07-01 | 2024-06-27 |
| Employee stock plan | S-8 | 2024-07-01 | - |
| Major company event | 8-K | 2024-06-20 | 2024-06-20 |
| Proxy materials | DEFA14A | 2024-06-17 | - |
| Proxy materials | DEFA14A | 2024-06-03 | - |
| Major company event | 8-K | 2024-06-03 | 2024-05-30 |
| Major company event | 8-K | 2024-05-02 | 2024-05-02 |
| Quarterly report | 10-Q | 2024-05-02 | 2024-03-31 |
| Proxy materials | DEFA14A | 2024-04-25 | - |
| Annual report to shareholders | ARS | 2024-04-25 | 2023-12-31 |
| Proxy statement | DEF 14A | 2024-04-25 | 2024-06-20 |
| Major company event | 8-K | 2024-04-08 | 2024-04-08 |
| Employee stock plan | S-8 | 2024-03-27 | - |
| Insider trade | 4 | 2024-03-07 | 2024-03-07 |
| Insider trade | 4 | 2024-03-07 | 2024-03-07 |
| Insider trade | 4 | 2024-03-07 | 2024-03-07 |
| Insider trade | 4 | 2024-03-07 | 2024-03-07 |
| Major company event | 8-K | 2024-02-29 | 2024-02-29 |
| Annual report | 10-K | 2024-02-29 | 2023-12-31 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-06 | - |
| Major company event | 8-K | 2024-01-08 | 2024-01-08 |
| Insider trade | 4 | 2023-12-19 | 2023-12-19 |